Navigation Links
Syngenta Holds Annual General Meeting
Date:4/23/2013

BASEL, Switzerland, April 23, 2013 /PRNewswire/ --

At the Annual General Meeting of Syngenta AG on April 23, 2013, the 1,142 shareholders representing 48.27% of the total shares approved all the motions proposed by the Board of Directors.

Shareholders also approved a dividend of CHF 9.50 per share, an increase of 19% over the previous year.

Martin Taylor retired from his position as Chairman of the Board having completed his term of office and, as previously announced, is succeeded by Michel Demaré who was appointed to the Board at the AGM in 2012. Peggy Bruzelius , Peter Thompson and Felix A. Weber also retired from the Board, having completed their terms of office.

Eleni Gabre-Madhin , co-founder and CEO of eleni LLC, and Eveline Saupper, Partner and Director with commercial law firm Homburger AG in Zurich, were elected as new members of the Board.

Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life.  For more information about us please go to http://www.syngenta.com.

Note to the editor:

The speech of the Chairman, the presentation of the CEO and images of the Annual General Meeting can be found at http://www.syngenta.com/agm2013.

Syngenta International AG

Media Office
CH-4002 Basel
Switzerland
Tel:    +41-61-323-2323
Fax:    +41-61-323-2424

http://www.syngenta.com

Media contacts:

Paul Barrett
Switzerland    +41-61-323-2323

Daniel Brax ton
Switzerland     +41-61-323-2323

Analyst/Investor contacts:

Jennifer Gough
Switzerland    +41-61-323-5059
USA    +1-202-737-6521

Lars Oestergaard
Switzerland     +41-61-323-6793
USA     +1-202-737-6520



'/>"/>
SOURCE Syngenta International AG
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Syngenta and Devgen enter insect control research partnership
2. Syngenta to acquire Pasteuria Bioscience
3. Pasteuria Bioscience to be Acquired by Syngenta
4. Syngenta Secures EU Approval For Next Generation Fungicide
5. Syngenta divests US flowers distribution and brokerage
6. Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
7. Syngenta Licenses Plant Sensory Systems' Technology
8. Bayer CropScience and Syngenta Submit Herbicide-tolerance Soybean Trait for Approval in Various Countries
9. Syngenta and Bayer CropScience Propose a Comprehensive Action Plan to Help Unlock EU Stalemate on Bee Health
10. Bunker Hill Community College Holds Biomedical Careers Graduation Ceremony
11. Chemical makes blind mice see; compound holds promise for treating humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... June 28, 2017 Michael Zasloff , ... University School of Medicine, and Founder, Chairman and CEO ... study that has helped clarify the function of alpha-Synuclein ... other neurodegenerative diseases. Denise Barbut , MD, FRCP, ... was senior co-author of the study. Published ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... three research projects accepted for presentation at the 33rd Annual Meeting of the ... – including some of the world’s top thought leaders in reproductive medicine – ...
(Date:6/28/2017)... and London, June 28, 2017 (PRWEB) , ... ... ... The latest release of Siemens’ STAR-CCM+® software for multiphysics computational fluid ... enable automated product design exploration and optimization. STAR-CCM+ version 12.04 introduces Design ...
(Date:6/28/2017)... NC (PRWEB) , ... June 28, 2017 , ... Studies ... might lead to an effective treatment for Parkinson’s disease. But what has not been ... should take place to gain the best results. , A new study coming out ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):